Preeclamptic toxemia: a disease ripe for proteomic discovery

References

• Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br. J. Obstet. Gynaecol.88, 876–881 (1981).
   PubMedGoogle Scholar
• Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension35, 367–372 (2000).
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol.161, 1200–1204 (1989).
   PubMed Web of Science ®Google Scholar
• Thomson NF, Thornton S, Clark JF. The effects of placental extracts from normotensive and preeclamptic women on vasoconstriction and oxidative metabolism. Am. J. Obstet. Gynecol.183, 206–210 (2000).
   PubMedGoogle Scholar
• Hayman R, Warren A, Brockelsby J, Johnson I, Baker P. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. Br. J. Obstet. Gynaecol.107, 108–115 (2000).
   Google Scholar
• Myers J, Mires G, Macleod M, Baker P. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension45, 258–263 (2005).
   PubMed Web of Science ®Google Scholar
• Hayman R, Warren A, Johnson I, Baker P. The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia. Am. J. Obstet. Gynecol.184, 1196–1203 (2001).
   Google Scholar
• Myers JE, Hart S, Armstrong S et al. Evidence for multiple circulating factors in preeclampsia. Am. J. Obstet. Gynecol.196(3), 266.e1–266.e6 (2007).
   Google Scholar
• Chappell LC, Seed PT, Briley A et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am. J. Obstet. Gynecol.187, 127–136 (2002).
   PubMed Web of Science ®Google Scholar
• Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV. First-trimester serum levels of soluble endoglin and soluble Fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am. J. Obstet. Gynecol.199(3), 266.e1–266.e6 (2008).
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Zhao G, Funai EF et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am. J. Obstet. Gynecol.199(5), 551.e1–551.e16 (2008).
   PubMed Web of Science ®Google Scholar
• Buhimschi CS, Norwitz ER, Funai E et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am. J. Obstet. Gynecol.192, 734–741 (2005).
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol.172, 649–653 (1995).
   PubMed Web of Science ®Google Scholar
• Park JS, Oh KJ, Norwitz ER et al. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod. Sci.15, 457–468 (2008).
   PubMedGoogle Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics1, 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24, 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Etzioni R, Urban N, Ramsey S et al. The case for early detection. Nat. Rev. Cancer3, 243–252 (2003).
   PubMed Web of Science ®Google Scholar
• O’Riordan E, Gross SS, Goligorsky MS. Technology insight: renal proteomics – at the crossroads between promise and problems. Nat. Clin. Pract. Nephrol.2, 445–458 (2006).
   Google Scholar
• Thongboonkerd V. Practical points in urinary proteomics. J. Proteome Res.6, 3881–3890 (2007).
   PubMed Web of Science ®Google Scholar
• Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry40, 4077–4086 (2001).
   Google Scholar
• Romero R, Kusanovic JP, Than NG et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am. J. Obstet. Gynecol.199, 122.e1–122.e11 (2008).
   Web of Science ®Google Scholar
• Nicolaides KH, Bindra R, Turan OM et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet. Gynecol.27, 13–17 (2006).
   PubMed Web of Science ®Google Scholar
• Robinson NJ, Wareing M, Hudson NK et al. Oxygen and the liberation of placental factors responsible for vascular compromise. Lab. Invest.88, 293–305 (2008).
   Google Scholar
• Watanabe H, Hamada H, Yamada N et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics4, 537–543 (2004).
   PubMed Web of Science ®Google Scholar
• Wang CC, Yim KW, Poon TC et al. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin. Chem.53, 42–52 (2007).
   PubMed Web of Science ®Google Scholar
• Myers J, Macleod M, Reed B, Harris N, Mires G, Baker P. Use of proteomic patterns as a novel screening tool in pre-eclampsia. J. Obstet. Gynaecol.24, 873–874 (2004).
   Google Scholar
• Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med.355, 992–1005 (2006).
   PubMed Web of Science ®Google Scholar
• McGuire JN, Overgaard J, Pociot F. Mass spectrometry is only one piece of the puzzle in clinical proteomics. Brief. Funct. Genomic. Proteomic.7, 74–83 (2008).
   PubMedGoogle Scholar
• Deutsch EW, Lam H, Aebersold R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep.9, 429–434 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics5, 573–588 (2006).
   PubMed Web of Science ®Google Scholar